Literature DB >> 12687552

Enhanced susceptibility to end-organ disease in the lupus-facilitating NZW mouse strain.

Chun Xie1, Xin J Zhou, Xuebin Liu, Chandra Mohan.   

Abstract

OBJECTIVE: Although the NZW mouse strain is phenotypically normal, fulminant lupus glomerulonephritis (GN) develops when NZW mice are bred to several other strains, such as NZB, BXSB, B6.Sle1, and B6.Yaa. Based on the observation that aging NZW mice exhibit histologic evidence of GN, we sought to test our hypothesis that NZW mice may be more susceptible to immune-mediated renal damage.
METHODS: NZW mice, as well as C57BL/6 (B6) and BALB/c control mice, were challenged with rabbit anti-glomerular basement membrane nephrotoxic sera (NTS), to induce renal disease. The different mouse strains were monitored for the degree of clinical disease, renal pathology, chemokine profiles, and cellular infiltrates.
RESULTS: Although the NZW and control strains showed similar glomerular deposits of rabbit Ig and exhibited similar levels of anti-rabbit xenogeneic immune response, the NZW mice had significantly worse pathologic changes and disease. Compared with the control strains, the NTS-injected NZW mice demonstrated significantly increased proteinuria, elevated blood urea nitrogen levels, more severe histologic GN and tubulointerstitial nephritis, increased glomerular crescent formation with macrophage and neutrophil infiltrates, elevated expression of CC and CXC chemokines (monocyte chemoattractant protein 1, RANTES, KC), and significantly accelerated mortality. Importantly, these changes occurred within a few days after NTS administration. Finally, (B6 x NZW)F(1) mice were as susceptible as the NZW parents, which indicates dominant NZW contributions.
CONCLUSION: Collectively, these findings support the notion that a lupus-facilitating genome may contribute to disease susceptibility by modulating the degree of immune-mediated end-organ damage. The availability of B6-based congenic strains bearing individual NZW-derived lupus susceptibility loci will permit future genetic dissection of end-organ susceptibility in murine lupus.

Entities:  

Mesh:

Year:  2003        PMID: 12687552     DOI: 10.1002/art.10887

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  29 in total

1.  IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.

Authors:  Vinh Nguyen; Irina Luzina; Horea Rus; Cosmin Tegla; Ching Chen; Violeta Rus
Journal:  J Immunol       Date:  2012-06-20       Impact factor: 5.422

Review 2.  Role of TWEAK in lupus nephritis: a bench-to-bedside review.

Authors:  Jennifer S Michaelson; Nicolas Wisniacki; Linda C Burkly; Chaim Putterman
Journal:  J Autoimmun       Date:  2012-06-22       Impact factor: 7.094

3.  Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays.

Authors:  Quan-Zhen Li; Quan Li Zhen; Chun Xie; Tianfu Wu; Meggan Mackay; Cynthia Aranow; Chaim Putterman; Chandra Mohan
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 4.  Dysregulated Lymphoid Cell Populations in Mouse Models of Systemic Lupus Erythematosus.

Authors:  Aurélie De Groof; Patrice Hémon; Olivier Mignen; Jacques-Olivier Pers; Edward K Wakeland; Yves Renaudineau; Bernard R Lauwerys
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

5.  Murine lupus strains differentially model unique facets of human lupus serology.

Authors:  L Li; S Nukala; Y Du; J Han; K Liu; J Hutcheson; S Pathak; Q Li; C Mohan
Journal:  Clin Exp Immunol       Date:  2012-05       Impact factor: 4.330

6.  Inhibition of podocyte FAK protects against proteinuria and foot process effacement.

Authors:  Hong Ma; Akashi Togawa; Keita Soda; Junhui Zhang; Sik Lee; Ming Ma; Zhiheng Yu; Thomas Ardito; Jan Czyzyk; Lonnette Diggs; Dominique Joly; Shinji Hatakeyama; Eiji Kawahara; Lawrence Holzman; Jun Lin Guan; Shuta Ishibe
Journal:  J Am Soc Nephrol       Date:  2010-06-03       Impact factor: 10.121

7.  Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background.

Authors:  S Rashtak; E Marietta; S Cheng; M Camilleri; M Pittelkow; C David; J Grande; J Murray
Journal:  Lupus       Date:  2010-02-08       Impact factor: 2.911

8.  B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice.

Authors:  Sun-Hee Hwang; Huiyin Lee; Miwako Yamamoto; Leigh A Jones; Jivanaah Dayalan; Richard Hopkins; Xin J Zhou; Felix Yarovinsky; John E Connolly; Maria A Curotto de Lafaille; Edward K Wakeland; Anna-Marie Fairhurst
Journal:  J Immunol       Date:  2012-11-12       Impact factor: 5.422

9.  Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.

Authors:  Anna-Marie Fairhurst; Chun Xie; Yuyang Fu; Andrew Wang; Christopher Boudreaux; Xin J Zhou; Ricardo Cibotti; Anthony Coyle; John E Connolly; Edward K Wakeland; Chandra Mohan
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

10.  The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis.

Authors:  Q-Z Li; J Zhou; R Yang; M Yan; Q Ye; K Liu; S Liu; X Shao; L Li; X-J Zhou; E K Wakeland; C Mohan
Journal:  Genes Immun       Date:  2009-03-05       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.